NasdaqGM - Nasdaq Real Time Price USD

CollPlant Biotechnologies Ltd. (CLGN)

5.44 +0.03 (+0.51%)
As of 1:38 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Yehiel Tal CEO & Director 751k -- 1952
Mr. Eran Rotem CPA Deputy CEO & CFO 528k -- 1968
Mr. Oren Fahimipoor Vice President of Operations 212k -- 1982
Dr. Elana Gazal Vice President of Research & Development 379k -- 1975
Prof. Oded Shoseyov Founder & Chief Scientist 384k -- 1956
Ms. Hadas Dreiher Horowitz Vice President of Human Resources -- -- 1977

CollPlant Biotechnologies Ltd.

Weizmann Science Park
4 Oppenheimer
Rehovot, 7670104
Israel
972 73 232 5600 https://www.collplant.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
75

Description

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Corporate Governance

CollPlant Biotechnologies Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 22, 2024 - May 27, 2024
CollPlant Biotechnologies Ltd. Earnings Call

Related Tickers

ORGS Orgenesis Inc.
0.5095
+1.49%
 
APTCF Advanced Proteome Therapeutics Corporation
0.0002
0.00%
 
SIGY Sigyn Therapeutics, Inc.
5.75
0.00%
 
BIO.DE Biotest Aktiengesellschaft
41.60
0.00%
 
WXIBF WuXi Biologics (Cayman) Inc.
1.6450
0.00%
 
CRPOF Ceapro Inc.
0.1845
0.00%
 
IVBXF Innovent Biologics, Inc.
4.8900
0.00%
 
NSCI.L NetScientific plc
63.00
0.00%
 
ALDVI.PA Advicenne S.A.
1.7100
+0.59%
 
MRZM Marizyme, Inc.
0.0950
0.00%